The technologies suite includes the Orchestrated Customer Engagement (OCE) Sales/Marketing, Master Data Management (MDM), ePromo, and Organization Manager applications.
The applications will be rolled out to approximately 14,000 users across more than 100 countries, according to Iqvia.
Earlier this year the company announced that it had won deals with Pierre Fabre, Recordati, and PruGen, among other clients in the US and Canada to deploy its commercial operations SaaS software, OCE.
Iqvia CEO Ari Bousbib also reported three new recent awards on the company’s second quarter 2018 earnings call.
“When we decided to invest and innovate, our intent was to capture a fair share of this market,” Bousbib said. The offering was launched in 2017 . Bousbib further emphasized the company’s goal of growing its technology business, calling the Iqvia “a technology company in aggregate.”
Iqvia’s second quarter 2018 results came in “above the high end” of the company’s expectations at $2.567bn, said Bousbib.
The company also recently announced the expansion of its alliance with Salesforce, through which the companies will release SaaS and technology-enabled services to automate clinical trial processes and reduce patient burden.
“Through this expansion of our partnership with Salesforce, we are using its best-in-class platforms and Salesforce Health Cloud, a cloud-based application, to build our growing one-of-a-kind technology suite to help drive health care forward for patients,” Tal Rosenberg, senior vice president, Global Technology Solutions at Iqvia told us at the time.
The multi-year venture with Salesforce was originally launched in April 2017.